WebMar 25, 2024 · Diacylglycerol kinase α (DGKA) is the first member discovered from the diacylglycerol kinase family, and it has been linked to the progression of various types of tumors. However, it is unclear whether DGKA is linked to the development of lung cancer. WebDiacylglycerol kinase kappa (DGKκ) has been termed a master regulator that controls the switch between the diacylglycerol and phosphatidic acid signalling pathways. In the brain different isoenzymes are expressed in different types of neurons, but a deficiency of DGKκ in neurons is an important factor in Fragile X syndrome, a common cause of ...
DGKA interacts with SRC/FAK to promote the metastasis of non …
WebOct 16, 2024 · Diacylglycerol (DG) kinase (DGK) phosphorylates DG to generate phosphatidic acid (PA). The α isozyme is activated by Ca2+ … WebOct 31, 1989 · Elevated levels of diacylglycerol and persistent activation/down-regulation of protein kinase C reduced the binding of phorbol dibutyrate to transformed cells. This phenomenon could be reversed by blocking the glycolytic pathway, thus indicating that neosynthesized diacylglycerol was responsible for persistent activation and down … florida national univ athletics
Frontiers Diacylglycerol Kinases (DGKs): Novel Targets for …
WebNK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention Petra U. Prinz 1, Anna N. Mendler , Dorothee Brech 1, Ilias Masouris , Ralph Oberneder2 and Elfriede Noessner 1 Helmholtz Zentrum M€unchen, Germany Research Center for Environmental Health, Institute of … WebIn Advances in Drug Research, 1996. 4.2.3 Diacylglycerol. DAG, which is the second product of PLC activation, may be an important signal molecule in the pancreatic B-cell … WebLung cancer is a leading cause of cancer deaths and efforts are underway to identify novel therapies to treat these tumors. Diacylglycerol kinase η (DGKη), an enzyme that phosphorylates diacylglycerol to form phosphatidic acid, has been shown to modulate MAPK signaling downstream of EGFR, which is an oncogenic driver in some lung … great western hospital swindon switchboard